Allogeneic Matched Related Donor Bone Marrow Transplantation for Pediatric Patients With Severe Aplastic Anemia Using “Low-dose” Cyclophosphamide, ATG Plus Fludarabine
Conclusion:
This small pilot study shows that this cytoreductive regimen could be considered as the standard of care for transplantation of pediatric patients with aplastic anemia from HLA-matched siblings.
Source: Journal of Pediatric Hematology Oncology - Category: Hematology Tags: Online Articles: Original Articles Source Type: research
More News: Anemia | Aplastic Anemia | Bone Marrow Transplant | Cancer & Oncology | Hematology | Methotrexate | Pediatrics | Study | Toxicology | Transplants